The pharmaceutical industry's argument against allowing negotiation is that lower prices will lead to less research and development and therefore fewer breakthrough, life saving drugs.
The truth is that we Americans are paying for the full cost of R&D and most other countries are only paying the marginal costs of actually producing the drug.
The best and simplest answer is for the US to allow re importation of medications creating a "world price" and spreading R&D costs to all customers.
|